Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group
Whole Body Low Dose CT (WBLDCT) has important advantages as a first-line imaging modality for bone disease assessment in patients with plasma cell disorders and has been included in the 2014 International Myeloma Working Group (IMWG) criteria for multiple myeloma (MM) definition. Nevertheless, stand...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172202/ https://www.ncbi.nlm.nih.gov/pubmed/30287814 http://dx.doi.org/10.1038/s41408-018-0124-1 |
_version_ | 1783360894218010624 |
---|---|
author | Moulopoulos, Lia A. Koutoulidis, Vassilis Hillengass, Jens Zamagni, Elena Aquerreta, Jesus D. Roche, Charles L. Lentzsch, Suzanne Moreau, Philippe Cavo, Michele Miguel, Jesus San Dimopoulos, Meletios A. Rajkumar, S. Vincent Durie, Brian G. M. Terpos, Evangelos Delorme, Stefan |
author_facet | Moulopoulos, Lia A. Koutoulidis, Vassilis Hillengass, Jens Zamagni, Elena Aquerreta, Jesus D. Roche, Charles L. Lentzsch, Suzanne Moreau, Philippe Cavo, Michele Miguel, Jesus San Dimopoulos, Meletios A. Rajkumar, S. Vincent Durie, Brian G. M. Terpos, Evangelos Delorme, Stefan |
author_sort | Moulopoulos, Lia A. |
collection | PubMed |
description | Whole Body Low Dose CT (WBLDCT) has important advantages as a first-line imaging modality for bone disease assessment in patients with plasma cell disorders and has been included in the 2014 International Myeloma Working Group (IMWG) criteria for multiple myeloma (MM) definition. Nevertheless, standardization guidelines for the optimal use of WBLDCT in MM patients are still lacking, preventing its more widespread use, both in daily practice and clinical trials. The aim of this report by the Bone Group of the IMWG is to provide practical recommendations for the acquisition, interpretation and reporting of WBLDCT in patients with multiple myeloma and other plasma cell disorders. |
format | Online Article Text |
id | pubmed-6172202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61722022018-10-09 Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group Moulopoulos, Lia A. Koutoulidis, Vassilis Hillengass, Jens Zamagni, Elena Aquerreta, Jesus D. Roche, Charles L. Lentzsch, Suzanne Moreau, Philippe Cavo, Michele Miguel, Jesus San Dimopoulos, Meletios A. Rajkumar, S. Vincent Durie, Brian G. M. Terpos, Evangelos Delorme, Stefan Blood Cancer J Article Whole Body Low Dose CT (WBLDCT) has important advantages as a first-line imaging modality for bone disease assessment in patients with plasma cell disorders and has been included in the 2014 International Myeloma Working Group (IMWG) criteria for multiple myeloma (MM) definition. Nevertheless, standardization guidelines for the optimal use of WBLDCT in MM patients are still lacking, preventing its more widespread use, both in daily practice and clinical trials. The aim of this report by the Bone Group of the IMWG is to provide practical recommendations for the acquisition, interpretation and reporting of WBLDCT in patients with multiple myeloma and other plasma cell disorders. Nature Publishing Group UK 2018-10-04 /pmc/articles/PMC6172202/ /pubmed/30287814 http://dx.doi.org/10.1038/s41408-018-0124-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Moulopoulos, Lia A. Koutoulidis, Vassilis Hillengass, Jens Zamagni, Elena Aquerreta, Jesus D. Roche, Charles L. Lentzsch, Suzanne Moreau, Philippe Cavo, Michele Miguel, Jesus San Dimopoulos, Meletios A. Rajkumar, S. Vincent Durie, Brian G. M. Terpos, Evangelos Delorme, Stefan Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group |
title | Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group |
title_full | Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group |
title_fullStr | Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group |
title_full_unstemmed | Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group |
title_short | Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group |
title_sort | recommendations for acquisition, interpretation and reporting of whole body low dose ct in patients with multiple myeloma and other plasma cell disorders: a report of the imwg bone working group |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172202/ https://www.ncbi.nlm.nih.gov/pubmed/30287814 http://dx.doi.org/10.1038/s41408-018-0124-1 |
work_keys_str_mv | AT moulopoulosliaa recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT koutoulidisvassilis recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT hillengassjens recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT zamagnielena recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT aquerretajesusd recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT rochecharlesl recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT lentzschsuzanne recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT moreauphilippe recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT cavomichele recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT migueljesussan recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT dimopoulosmeletiosa recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT rajkumarsvincent recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT duriebriangm recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT terposevangelos recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup AT delormestefan recommendationsforacquisitioninterpretationandreportingofwholebodylowdosectinpatientswithmultiplemyelomaandotherplasmacelldisordersareportoftheimwgboneworkinggroup |